Related Experiment Videos

[Detection of coronary disease before valve surgery. Contribution of myocardial scintigraphy with dipyridamole]

P Aubry1, P Assayag, M Faraggi

  • 1Service de Cardiologie, CHU Beaujon, Clichy.

Annales De Cardiologie Et D'Angeiologie
|January 1, 1991
PubMed

Insights

Myocardial scintigraphy with dipyridamole (MS-DP) shows low sensitivity for detecting coronary artery disease in valve disease patients. MS-DP is not recommended for guiding coronary arteriography before valve surgery.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Cardiovascular Surgery

Background:

  • Detecting coronary artery disease (CAD) before valve surgery is challenging without coronary arteriography.
  • Myocardial scintigraphy with dipyridamole (MS-DP) is a non-invasive imaging technique.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of MS-DP in detecting CAD in patients undergoing valve surgery.
  • To assess the utility of MS-DP in guiding decisions for coronary arteriography.

Main Methods:

  • 34 consecutive patients with valve disease underwent both MS-DP and coronary arteriography.
  • Coronary arteriography was indicated by angina or age criteria.
  • CAD was defined by >70% stenosis on arteriography; MS-DP was positive for perfusion defects.

Main Results:

  • Coronary disease was present in 38% of patients (13/34).
  • MS-DP correctly identified CAD in 69% (sensitivity) and ruled it out in 95% (specificity).
  • Positive MS-DP significantly increased the predictive value of angina for CAD from 52% to 90%.

Conclusions:

  • MS-DP has high specificity but limited sensitivity for detecting CAD in this population.
  • Relying solely on MS-DP results to decide on coronary arteriography before valve surgery is not advisable due to its low sensitivity.

Related Concept Videos